These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 21647160)
1. Intensified chemotherapy inspired by a pediatric regimen combined with allogeneic transplantation in adult patients with acute lymphoblastic leukemia up to the age of 40. Rijneveld AW; van der Holt B; Daenen SM; Biemond BJ; de Weerdt O; Muus P; Maertens J; Mattijssen V; Demuynck H; Legdeur MC; Wijermans PW; Wittebol S; Spoelstra FM; Dekker AW; Ossenkoppele GJ; Willemze R; Cornelissen JJ; Leukemia; 2011 Nov; 25(11):1697-703. PubMed ID: 21647160 [TBL] [Abstract][Full Text] [Related]
2. Phase II study of intensive post-remission chemotherapy and stem cell transplantation for adult acute lymphoblastic leukemia and lymphoblastic lymphoma: Japan Clinical Oncology Group Study, JCOG9402. Azuma T; Tobinai K; Takeyama K; Shibata T; Hidaka M; Kurosawa M; Kasai M; Chou T; Fukushima N; Mukai K; Tsukasaki K; Shimoyama M; Jpn J Clin Oncol; 2012 May; 42(5):394-404. PubMed ID: 22422899 [TBL] [Abstract][Full Text] [Related]
3. [Comparison of the efficiency of CHOP-based regimen with or without high dose consolidation treatment combined with hematopoietic stem cell transplantation in 63 lymphoblastic lymphoma patients]. Qin Y; Shi YK; He XH; Han XH; Zhou SY; Liu P; Yang JL; Yang S; Zhang CG; Dong M; Zhou LQ; Wang JW; Feng FY; Sun Y Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):469-73. PubMed ID: 19950562 [TBL] [Abstract][Full Text] [Related]
4. Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA-94 trials. Boissel N; Auclerc MF; Lhéritier V; Perel Y; Thomas X; Leblanc T; Rousselot P; Cayuela JM; Gabert J; Fegueux N; Piguet C; Huguet-Rigal F; Berthou C; Boiron JM; Pautas C; Michel G; Fière D; Leverger G; Dombret H; Baruchel A J Clin Oncol; 2003 Mar; 21(5):774-80. PubMed ID: 12610173 [TBL] [Abstract][Full Text] [Related]
5. DV-ICE, intensive induction and early transplantation for adult patients with acute lymphoblastic leukemia: a phase II study. Dudler C; Bargetzi M; Tichelli A; Gratwohl A; Passweg JR; Wernli M Eur J Haematol; 2009 Dec; 83(6):512-8. PubMed ID: 19614953 [TBL] [Abstract][Full Text] [Related]
6. Pediatric-inspired therapy in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: the GRAALL-2003 study. Huguet F; Leguay T; Raffoux E; Thomas X; Beldjord K; Delabesse E; Chevallier P; Buzyn A; Delannoy A; Chalandon Y; Vernant JP; Lafage-Pochitaloff M; Chassevent A; Lhéritier V; Macintyre E; Béné MC; Ifrah N; Dombret H J Clin Oncol; 2009 Feb; 27(6):911-8. PubMed ID: 19124805 [TBL] [Abstract][Full Text] [Related]
7. High complete remission rate and promising outcome by combination of imatinib and chemotherapy for newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia: a phase II study by the Japan Adult Leukemia Study Group. Yanada M; Takeuchi J; Sugiura I; Akiyama H; Usui N; Yagasaki F; Kobayashi T; Ueda Y; Takeuchi M; Miyawaki S; Maruta A; Emi N; Miyazaki Y; Ohtake S; Jinnai I; Matsuo K; Naoe T; Ohno R; J Clin Oncol; 2006 Jan; 24(3):460-6. PubMed ID: 16344315 [TBL] [Abstract][Full Text] [Related]
9. [Concept and interim result of the ALL-BFM 90 therapy study in treatment of acute lymphoblastic leukemia in children and adolescents: the significance of initial therapy response in blood and bone marrow]. Schrappe M; Reiter A; Sauter S; Ludwig WD; Wörmann B; Harbott J; Bender-Götze C; Dörffel W; Dopfer R; Frey E Klin Padiatr; 1994; 206(4):208-21. PubMed ID: 7526027 [TBL] [Abstract][Full Text] [Related]
10. Acute lymphoblastic leukemia in young adults: two chemotherapeutic protocols for the treatment of 46 patients. Ho CL; Chen YC; Kao WY; Chao TY Zhonghua Yi Xue Za Zhi (Taipei); 2000 Jan; 63(1):45-52. PubMed ID: 10645050 [TBL] [Abstract][Full Text] [Related]
11. Comparison of intensive chemotherapy, allogeneic or autologous stem cell transplantation as post-remission treatment for adult patients with high-risk acute lymphoblastic leukemia. Results of the PETHEMA ALL-93 trial. Ribera JM; Oriol A; Bethencourt C; Parody R; Hernández-Rivas JM; Moreno MJ; del Potro E; Torm M; Rivas C; Besalduch J; Sanz MA; Ortega JJ; Haematologica; 2005 Oct; 90(10):1346-56. PubMed ID: 16219571 [TBL] [Abstract][Full Text] [Related]
12. Role of allogenic bone marrow transplantation in adolescent or adult patients with acute lymphoblastic leukaemia or lymphoblastic lymphoma in first remission. De Witte T; Awwad B; Boezeman J; Schattenberg A; Muus P; Raemaekers J; Preijers F; Strijckmans P; Haanen C Bone Marrow Transplant; 1994 Nov; 14(5):767-74. PubMed ID: 7889010 [TBL] [Abstract][Full Text] [Related]
13. Antimetabolite-based therapy in childhood T-cell acute lymphoblastic leukemia: a report of POG study 9296. Winter SS; Holdsworth MT; Devidas M; Raisch DW; Chauvenet A; Ravindranath Y; Ducore JM; Amylon MD Pediatr Blood Cancer; 2006 Feb; 46(2):179-86. PubMed ID: 16007607 [TBL] [Abstract][Full Text] [Related]
15. Reduced-intensity conditioning allogeneic stem cell transplantation is a potential therapeutic approach for adults with high-risk acute lymphoblastic leukemia in remission: results of a prospective phase 2 study. Cho BS; Lee S; Kim YJ; Chung NG; Eom KS; Kim HJ; Min CK; Cho SG; Kim DW; Lee JW; Min WS; Kim CC Leukemia; 2009 Oct; 23(10):1763-70. PubMed ID: 19440217 [TBL] [Abstract][Full Text] [Related]
16. Comparison of the results of the treatment of adolescents and young adults with standard-risk acute lymphoblastic leukemia with the Programa Español de Tratamiento en Hematología pediatric-based protocol ALL-96. Ribera JM; Oriol A; Sanz MA; Tormo M; Fernández-Abellán P; del Potro E; Abella E; Bueno J; Parody R; Bastida P; Grande C; Heras I; Bethencourt C; Feliu E; Ortega JJ J Clin Oncol; 2008 Apr; 26(11):1843-9. PubMed ID: 18398150 [TBL] [Abstract][Full Text] [Related]
17. Short intensive sequential therapy followed by autologous stem cell transplantation in adult Burkitt, Burkitt-like and lymphoblastic lymphoma. van Imhoff GW; van der Holt B; MacKenzie MA; Ossenkoppele GJ; Wijermans PW; Kramer MH; van 't Veer MB; Schouten HC; van Marwijk Kooy M; van Oers MH; Raemaekers JM; Sonneveld P; Meulendijks LA; Kluin PM; Kluin-Nelemans HC; Verdonck LF; Leukemia; 2005 Jun; 19(6):945-52. PubMed ID: 15800666 [TBL] [Abstract][Full Text] [Related]
18. Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system. Harker-Murray PD; Thomas AJ; Wagner JE; Weisdorf D; Luo X; DeFor TE; Verneris MR; Dusenbery KE; MacMillan ML; Tolar J; Baker KS; Orchard PJ Biol Blood Marrow Transplant; 2008 Jun; 14(6):685-92. PubMed ID: 18489994 [TBL] [Abstract][Full Text] [Related]
19. Treatment of refractory acute lymphoblastic leukemia in adults with high dose cytosine arabinoside and mitoxantrone (HAM). Hiddemann W; Büchner T; Heil G; Schumacher K; Diedrich H; Maschmeyer G; Ho AD; Planker M; Gerith-Stolzenburg S; Donhuijsen-Ant R Leukemia; 1990 Sep; 4(9):637-40. PubMed ID: 2395383 [TBL] [Abstract][Full Text] [Related]
20. [Treatment of adult acute lymphoblastic leukemia according to GMALL 07/2003 study protocol in the Czech Republic - the first experience]. Folber F; Sálek C; Doubek M; Soukupová Maaloufová J; Valová T; Trka J; Gökbuget N; Vydra J; Kozák T; Horácek JM; Zák P; Cetkovský P; Hoelzer D; Mayer J Vnitr Lek; 2010 Mar; 56(3):176-82. PubMed ID: 20394203 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]